Fox Chase Cancer Center Proudly Supports the 20th Annual Run/Walk to Break the Silence on Ovarian Cancer

PHILADELPHIA (August 23, 2018) – Fox Chase Cancer Center is pleased to support the National Ovarian Cancer Coalition’s (NOCC) 20th Annual Philadelphia Run/Walk to Break the Silence on Ovarian Cancer. Faculty and staff, volunteers, patients, survivors, and their families will come together at this family-friendly 5K run/walk to raise funds to support ovarian cancer research and advocacy on Saturday, September 8.

Fox Chase is the sole organization that has sponsored this event every year. NOCC has invited Stephen C. Rubin, MD, chief of gynecologic oncology at Fox Chase, to present a toast to all ovarian cancer survivors at the event.

“I am honored to represent Fox Chase at the Run/Walk to Break the Silence on Ovarian Cancer, and grateful to NOCC for the opportunity to speak,” said Rubin.

The event starts at 8 A.M. at Memorial Hall in Fairmount Park. Registration opens at 6:45 A.M. For more information about this event, to register to join the Fox Chase team, or to make a donation, visit https://runwalk.ovarian.org/philadelphia/.

 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text